Etiracetam
Modify Date: 2024-01-14 12:25:07
Etiracetam structure
|
Common Name | Etiracetam | ||
|---|---|---|---|---|
| CAS Number | 103765-01-1 | Molecular Weight | 170.209 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 395.9±25.0 °C at 760 mmHg | |
| Molecular Formula | C8H14N2O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 193.2±23.2 °C | |
| Name | (2R)-2-(2-oxopyrrolidin-1-yl)butanamide |
|---|---|
| Synonym | More Synonyms |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 395.9±25.0 °C at 760 mmHg |
| Molecular Formula | C8H14N2O2 |
| Molecular Weight | 170.209 |
| Flash Point | 193.2±23.2 °C |
| Exact Mass | 170.105530 |
| PSA | 64.39000 |
| LogP | -0.67 |
| Vapour Pressure | 0.0±0.9 mmHg at 25°C |
| Index of Refraction | 1.519 |
|
Inhibition of excitatory synaptic transmission in hippocampal neurons by levetiracetam involves Zn²⁺-dependent GABA type A receptor-mediated presynaptic modulation.
J. Pharmacol. Exp. Ther. 348(2) , 246-59, (2014) Levetiracetam (LEV) is an antiepileptic drug with a unique but as yet not fully resolved mechanism of action. Therefore, by use of a simplified rat-isolated nerve-bouton preparation, we have investiga... |
|
|
Efficacy and safety of pregabalin versus levetiracetam as adjunctive therapy in patients with partial seizures: a randomized, double-blind, noninferiority trial.
Epilepsia 55(7) , 1048-57, (2014) To assess the comparative efficacy and safety of pregabalin and levetiracetam for the reduction of seizure frequency in patients with partial seizures.This was a randomized, double-blind, flexible-dos... |
|
|
[Epilepsy in the elderly].
Tidsskr. Nor. Laegeforen. 133(5) , 528-31, (2013) Diagnostic work-up and treatment of patients who have developed epilepsy after the age of 65 can both be difficult. Epilepsy is one of the most common neurological conditions in the elderly, and the i... |
| 1-Pyrrolidineacetamide, α-ethyl-2-oxo- |
| (2R)-2-(2-Oxo-1-pyrrolidinyl)butanimidic acid |
| 1-Pyrrolidineethanimidic acid, α-ethyl-2-oxo-, (αR)- |
| Etiracetam, R-(+)- |
| (±)-a-Ethyl-2-oxo-1-pyrrolidineacetamide |
| (2R)-2-(2-oxopyrrolidin-1-yl)butanamide |
| T5NVTJ AY2&VZ |
| (R)-2-(2-oxopyrrolidin-1-yl)butanamide |
| Etiracetam |
| 1-Pyrrolidineacetamide, α-ethyl-2-oxo-, (αR)- |
| 2-(2-Oxo-1-pyrrolidinyl)butanamide |
| α-Ethyl-2-oxo-1-pyrrolidineacetamide |
| UNII:230447L0GL |
| C8H14N2O2 |
| Torleva |
| 乙拉西坦 |
| 2-(2-Oxopyrrolidin-1-yl)butyramide |
| ucb L060 |
| (±)-α-Ethyl-2-oxo-1-pyrrolidineacetamide |
| Leviteracetam |
| (2R)-2-(2-Oxo-1-pyrrolidinyl)butanamide |
| 2-(2-oxopyrrolidin-1-yl)butanamide |
| LEVITIRACETAM |
| Levetiracetam Impurity 4 |